EpiPen's Dominance Driven By Competitors' Stumbles And Tragic Deaths
The company's lobbying of state legislatures is just one factor in EpiPen's dominance of the market. Manufacturers of competing devices have struggled to gain a foothold.
Read more on NPR
September 7, 2016 at 11:50PM
Health Care
NPR News: EpiPen's Dominance Driven By Competitors' Stumbles And Tragic Deaths
Related Posts:
NPR News: Simplified Study Aims To Quickly Test A Long-Shot ALS Treatment- NPR News: Trump Blasts Obamacare At His Miami Golf Course But Misstates Employees' Coverage
- NPR News: Trump Blasts Obamacare At His Miami Golf Course But Misstates Employees' Coverage
- NPR News: Applying A Silicon Valley Approach To Jumpstart Medical Research
- NPR News: Applying A Silicon Valley Approach To Jumpstart Medical Research
0 nhận xét:
Đăng nhận xét